Sustainability disclosures
Sustainability disclosures
Clear, credible sustainability reporting is now a baseline expectation — and a growing source of strategic advantage.
We support clients in structuring, prioritising, and delivering fit-for-purpose sustainability disclosures
Investors, customers, regulators, and employees are demanding greater transparency and accountability, while global reporting standards are becoming more robust and harmonised. With the right approach, sustainability disclosures can do more than meet requirements; they can strengthen positioning, drive internal alignment, and unlock long-term value.
We support clients in structuring, prioritising, and delivering fit-for-purpose sustainability disclosures that meet regulatory demands and stakeholder expectations, while communicating ambition and impact. Our work leverages recognised standards and frameworks to ensure reports are compliant, comparable, and strategically grounded.
Materiality assessments
We design and execute both single and double materiality assessments (DMAs) to identify not only sustainability risks, but also opportunities that can drive differentiation and long-term value. Our approach is fully CSRD-compliant and supports clients from initial scoping and stakeholder engagement to implications analysis and auditor dialogue. For us, a DMA is not just a compliance exercise, it’s a strategic tool to guide where and how sustainability can create the most impact.
Developing CSRD reports and readiness assessments
We help clients prepare for the Corporate Sustainability Reporting Directive (CSRD) by translating requirements into a clear and actionable reporting roadmap. Our end-to-end support includes double materiality assessments, identification of relevant datapoints, gap analysis, mobilisation of internal teams, policy development, and full CSRD report execution. We ensure reporting is not only compliant but aligned with the company’s sustainability strategy and broader business goals.
Sustainability reports development
We guide the full development of strategic, comprehensive sustainability reports, from initial concept and data gathering through to content creation, review processes, and design collaboration. Our reports go beyond compliance to clearly communicate ambition, progress, and impact, enabling companies to proactively engage with stakeholders. We ensure alignment with both regulatory frameworks and stakeholder expectations while shaping a credible and compelling sustainability narrative.
Our featured cases within sustainability disclosures
- CIPabout ?overlay=cip
CIP
Sustainability reporting for leading fund manager within renewable energy infrastructure
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Novo Nordiskabout ?overlay=novo-nordisk
Novo Nordisk
ESG industry reporting benchmark
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Polarisabout ?overlay=polaris
Polaris
Sustainability strategy & ESG reporting benchmark in private equity
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Value creation & commercialisationabout /services/value-creation-and-commercialisationValue creation & commercialisation
- Telia Denmark about ?overlay=telia-denmark
Telia Denmark
Scope 1-3 baseline, sustainability strategy & target setting for large Telco player
- Decarbonisation & transitionabout /services/decarbonisation-and-transitionDecarbonisation & transition
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Zealand Pharmaabout ?overlay=zealand-pharma
Zealand Pharma
CSRD readiness and ESG Strategy in healthcare
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Sustainability strategy & organisationabout /services/sustainability-strategy-and-organisationSustainability strategy & organisation
Subscribe to our Sustainability Reporting mailing list
Subscribe to join our EU Sustainability Reporting mailing list
We have an EU sustainability reporting mailing list that provides clear updates on CSRD and other EU sustainability reporting developments, practical explanations of what new rules mean for organisations, and answers to common questions. You can sign up for our mailing list below.
“We help companies turn sustainability reporting from a compliance burden into a strategic asset - anchoring credibility, aligning stakeholders, and unlocking value through clear, transparent, and forward-looking disclosures.”
Explore our full range of services supporting every step of the sustainability journey
- Private equity and investors
- Strategy and value creation
- Reporting and regulation
- Nature and resources
- Climate
We support investors across the full investment cycle, from fund strategy and impact priorities to Due Diligence, ownership and exit. Our work helps embed sustainability and impact throughout, unlocking long-term value and stronger outcomes.
- Sustainable fundsabout /services/sustainable-fundsSustainable funds
- Private equity servicesabout /services/private-equity-servicesPrivate equity services
Explore our full range of services supporting every step of the sustainability journey
We support investors across the full investment cycle, from fund strategy and impact priorities to Due Diligence, ownership and exit. Our work helps embed sustainability and impact throughout, unlocking long-term value and stronger outcomes.
- Sustainable fundsabout /services/sustainable-fundsSustainable funds
- Private equity servicesabout /services/private-equity-servicesPrivate equity services
Zealand Pharma
CSRD readiness and ESG Strategy in healthcare
Zealand Pharma is an international biotechnology company developing innovative peptide-based medicines in three key therapeutic areas: obesity, rare diseases, and chronic inflammation. In preparation for upcoming CSRD requirements and to strengthen its sustainability ambitions, Zealand Pharma partnered with The Footprint Firm to develop a Double Materiality Assessment (DMA) and revisit its ESG strategy, linking regulatory compliance with long-term strategic value.
Services
- Sustainability disclosuresabout /services/sustainability-disclosuresSustainability disclosures
- Sustainability strategy & organisationabout /services/sustainability-strategy-and-organisationSustainability strategy & organisation
Industries
- Biotechnology
- Pharmaceuticals & healthcare
The project
Zealand Pharma sought to establish a robust Double Materiality Assessment that could serve both as the analytical foundation for compliance and upcoming CSRD reporting and as a strategic tool to inform its ESG direction. The aim was to ensure cross-organisational alignment, engage senior leadership, and use the DMA process to guide the development of an updated, actionable ESG strategy.
Our approach
Working closely with the finance, strategy, and sustainability teams, we facilitated a CSRD-compliant DMA process grounded in stakeholder interviews and engagement with corporate management. The assessment identified material impacts, risks, and opportunities across environmental, social, and governance topics, aligned with CSRD requirements while tailored to Zealand Pharma’s unique context as a biotech innovator.
Building on this foundation, we co-developed an updated ESG strategy structured around three core pillars: Patients, People, and Operations. Each pillar was translated into clear initiatives, measurable targets, and linked CSRD datapoints, ensuring both strategic relevance and reporting readiness.
We also helped map internal ownership by connecting each pillar with relevant data owners and operational leads to embed sustainability across the organisation.
The impact
Our collaboration enabled Zealand Pharma to move from regulatory preparation to strategic integration, delivering a CSRD-ready Double Materiality Assessment and a refreshed ESG strategy rooted in business priorities.
The result: an ESG roadmap that is both compliant and value-generating, with clear internal ownership and a structure that connects Zealand Pharma’s mission to the company’s sustainability performance as a whole.